CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.
Under current guidelines, discontinuation of oral anticoagulant therapy is not considered to be a benefit that can be routinely offered to patients who have undergone ablation for atrial fibrillation. Even after apparently successful ablation, continuation of anticoagulant therapy is recommended when indicated by the CHA2DS2 -VASc score...
This review summarizes cardiac physiologic pacing for heart failure, highlighting benefits of biventricular pacing and emerging evidence for His-bundle and left bundle-branch pacing to improve function and outcomes.
With increasing numbers of PCPs leaving traditional practice for concierge medicine or direct primary care, NOS host Lisa Rosenbaum and her guests explore the promise and perils.
In patients with atrial fibrillation after successful ablation, rivaroxaban therapy did not lead to a significantly lower incidence of a composite of stroke, systemic embolism, or new covert embolic stroke than aspirin therapy.
The management of carotid-artery stenosis that has not caused recent symptoms — asymptomatic carotid stenosis — has been controversial. Clinical trials that began more than 30 years ago showed a small benefit of carotid endarterectomy as compared with medical treatment, but improvements in medical prevention of stroke call into question...